Investing News
Market News
Immuron Limited Received FDA Guidance on the clinical development plans for new oral therapeutic
Immuron Limited (NASDAQ: IMRN) shares jumped more than 140% after the Company announced announce that the Naval Medical Research Center (NMRC) has received written guidance from the U.S. Food and...